from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0590/mce2B

LFCtreatmentdescriptionclass of inhibitor

-1.312

Amikacinug/mL Amikacintranslation

-2.228

Cap5-10ug/mL Capreomycintranslation

-2.004

Rox10-50 ug/mL Roxithromycintranslation

-0.204

SM2-5 ug/mL Streptomycintranslation

0.231

Tet5-10 ug/mL Tetracyclinetranslation

0.494

Rif0.2-5ug/mL Rifampicintranscription

0.324

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.299

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.757

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.050

CPZ10-50 ug/mL Chlorpromazinerespiration

0.105

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.415

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.802

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.127

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.461

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.203

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.274

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.126

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.118

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.764

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.852

KCN5-20 ug/mL Potassium cyaniderespiration

-0.642

NaN30.2-2 mM Sodium aziderespiration

-1.112

Nigericin50 uM Nigericinrespiration

-0.509

TRC10-150 ug/mL Triclosanrespiration

0.073

TRZ10-25 ug/mL Thioridazinerespiration

-0.479

Valinomycin0.5-10 uM Valinomycinrespiration

-0.635

ZnSO42 mM ZnSO4respiration

-0.352

menadione6-10 ug/mL Menadionerespiration

1.294

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.344

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.228

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.562

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.012

NRP_1Non-replicating persistence stage 1dosRassociated

0.007

Amp0.2mg/mL AmpicillincellWall

0.235

Cephalexin20-100 ug/mL CephalexincellWall

0.135

Cerulenin0.32-5 ug/mL CerulenincellWall

0.343

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.238

EMB10-20 ug/mL EthambutolcellWall

-0.218

Eta12-40 ug/mL EthionamidecellWall

-0.260

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.467

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.268

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.121

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.073

BZA0.12 mg/mL BenzamidearomaticAmides

0.019

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.080

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.105

H2O24 mM hydrogen peroxideDNAdamaging

0.008

Levo10 ug/mL LevofloxacinDNAdamaging

-0.276

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.361

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.338

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.061

UVUV-irradiationDNAdamaging

-1.128

ARP41-4 ug/mL Antitubercular compound ARP4?

0.128

Antimycin12.5-50 ug/mL Antimycin A?

0.943

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.595

PA_110-50 ug/mL Antitubercular compound PA-1?

0.377

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.440

PA8240.2-2 ug/mL PA-824?

1.273

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.244

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.518

Verapamil50 uM Verapamil?

0.507

mercaptoethanol2 mM 2-Mercaptoethanol?

0.285

methoxatin10-20 ug/mL Methoxatin?